Satellite Bio
PrivateLast Round
Seed
Apr 20, 2022
Total Funding Raised
$110M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Satellite Bio is a biotechnology company that develops innovative cell therapies through proprietary, off-the-shelf, implantable satellite organs aimed at treating complex diseases and improving patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Satellite Bio Comparables
Compare Satellite Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LyGenesis | 81% | |
| Trestle Biotherapeutics | 81% | |
| Aspect Biosystems | 77% |
Satellite Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 20, 2022 |
Key People
Founding team and executive leadership
Satellite Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Seed |
| Waterman Ventures | Seed |
| Catalio Capital Management | Seed |
| aMoon | Seed |
| Polaris Partners | Seed |
| Alumni Ventures | Seed |
| Lightspeed Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 39% MoM, reaching 2.1K.
- Jun 21, 2026
Monthly visitors increased 135% MoM, reaching 1.3K.
Satellite Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Satellite Bio's valuation, stock price, and market status.
Is Satellite Bio a public or private company?
Satellite Bio is a private company.
What is the current stock price of Satellite Bio?
Satellite Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Satellite Bio worth (valuation)?
Valuation information for Satellite Bio is not publicly available.
Can I buy Satellite Bio stock?
Satellite Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Satellite Bio's last funding round?
Satellite Bio's most recent funding round was Series A on April 20, 2022.
Who are the main investors in Satellite Bio?
Key investors in Satellite Bio include aMoon, Lightspeed Venture Partners.
Will Satellite Bio IPO soon?
No public IPO plans have been announced for Satellite Bio.
How can I track Satellite Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Satellite Bio's secondary market activity and sign up for updates.